<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9291">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05701163</url>
  </required_header>
  <id_info>
    <org_study_id>21-10024093</org_study_id>
    <nct_id>NCT05701163</nct_id>
  </id_info>
  <brief_title>Assessing the Effect of Abstinence Period on Semen Parameters</brief_title>
  <official_title>Assessing the Effect of Abstinence Period on Semen Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to learn about the impact of abstinence periods on sperm quality in&#xD;
      healthy males 20-45 years of age with no significant comorbidities who are able to produce a&#xD;
      semen sample via masturbation. The main question it aims to answer is:&#xD;
&#xD;
      • Do shorter abstinence periods result in improved semen quality?&#xD;
&#xD;
      Participants will provide semen samples for analysis following abstinence periods of 7 days,&#xD;
      5 days, 2 days, 1 day, and 3 hours.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participant Duration: Total length of time on study per subject is 14 days (including 5 days&#xD;
      of visit required for sample production). Subjects do not need to complete the visits in&#xD;
      order but need to document abstinence period prior to sample production. No follow up will be&#xD;
      needed after the study.&#xD;
&#xD;
      Primary Objective: The primary objective is to examine the differences in semen analysis&#xD;
      parameters after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).&#xD;
&#xD;
      Secondary Objectives: The secondary objective(s) is to assess changes in sperm DNA&#xD;
      fragmentation after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2023</start_date>
  <completion_date type="Anticipated">February 2027</completion_date>
  <primary_completion_date type="Anticipated">February 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in semen analysis parameters based on different abstinence periods: volume</measure>
    <time_frame>7 days, 5 days, 2 days, 1 day, 3 hours</time_frame>
    <description>The primary objective is to examine the differences in semen analysis parameters (volume in mL) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in semen analysis parameters based on different abstinence periods: sperm concentration</measure>
    <time_frame>7 days, 5 days, 2 days, 1 day, 3 hours</time_frame>
    <description>The primary objective is to examine the differences in semen analysis parameters (sperm concentration measured in million sperm/mL) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in semen analysis parameters based on different abstinence periods: motility</measure>
    <time_frame>7 days, 5 days, 2 days, 1 day, 3 hours</time_frame>
    <description>The primary objective is to examine the differences in semen analysis parameters (motility measured as a percentage) after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in sperm DNA fragmentation based on different abstinence periods</measure>
    <time_frame>7 days, 5 days, 2 days, 1 day, 3 hours</time_frame>
    <description>The secondary objective(s) is to assess changes in sperm DNA fragmentation after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infertility, Male</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy males with no significant comorbidities, aged 20-45 years who are able to produce a semen sample by masturbation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Abstinence followed by semen sample collection.</intervention_name>
    <description>Abstinence is the intervention. Semen samples will be collected after abstinence periods.</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males, aged 20-45 years&#xD;
&#xD;
          -  Healthy, no significant comorbidities&#xD;
&#xD;
          -  Able to produce a semen sample by masturbation&#xD;
&#xD;
          -  Total sperm count ≥ 1 million sperm&#xD;
&#xD;
          -  Abnormal sperm DNA fragmentation (TUNEL assay value ≥ 20%)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 20 or &gt; 45 years&#xD;
&#xD;
          -  Significant comorbidities, including significant cardiac, pulmonary, gastrointestinal,&#xD;
             hematologic, or neurologic disease&#xD;
&#xD;
          -  Total sperm count &lt; 1 million sperm&#xD;
&#xD;
          -  Aspermia (semen volume = 0)&#xD;
&#xD;
          -  Normal sperm DNA fragmentation (TUNEL assay value &lt; 20%)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Gal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grace Tan, MA</last_name>
    <phone>2127463208</phone>
    <email>grt2008@med.cornell.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Akeem Noziere</last_name>
    <phone>2127464745</phone>
    <email>akn4001@med.cornell.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Tan, MA</last_name>
      <phone>212-746-3208</phone>
      <email>grt2008@med.cornell.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jonathan Gal, MD</last_name>
      <phone>2127463208</phone>
      <email>jog4018@med.cornell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Gal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>December 23, 2022</study_first_submitted>
  <study_first_submitted_qc>January 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2023</study_first_posted>
  <last_update_submitted>April 18, 2023</last_update_submitted>
  <last_update_submitted_qc>April 18, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

